PET-CT - Introduction
Positron Emission Tomography – Computed Tomography (PET-CT) is a sophisticated hybrid imaging technique that allows the visualization of human anatomy and metabolic activity by using x-ray and a small amount of short-lived positron emitting radiopharmaceuticals. It has been playing an indispensable role in the management of patients in oncology. It provides information in tumor detection and grading, as well as treatment response monitoring and disease recurrence detection.
Following service commencement of the new cyclotron of our hospital in January 2019, our patients are now provided with a comprehensive range of positron-emitting radiotracers, including F18-FDG as well as latest radiotracers such as C11-Acetate, F18-PSMA, F18-FDOPA, C11-PIB etc. (see attached table for details).
Together with the department’s two PET-CT and the latest PET-MR scanners, a new series of examinations will be available not only to our oncologic but also neurological patients. The C11-Acetate and F18-FDG dual tracers PET scan provides the most advanced and comprehensive assessment for liver cancer patients. F18-PSMA provides a more accurate diagnosis for patients with prostate cancer while C11-PIB and F18-FDOPA provide diagnostic insight for management of patients with Alzheimer’s and Parkinson’s disease respectively. You are most welcome to call us at 27148263 or visit our department for further enquiries.
List of Novel PET Radiotracers Available in Scanning Department, St. Teresa’s Hospital